These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 6401168)

  • 1. Pharmacokinetics and metabolism of sodium 2-mercaptoethanesulfonate in the rat.
    Ormstad K; Orrenius S; Låstbom T; Uehara N; Pohl J; Stekar J; Brock N
    Cancer Res; 1983 Jan; 43(1):333-8. PubMed ID: 6401168
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of dimesna to mesna by the isolated perfused rat liver.
    Goren MP; Hsu LC; Li JT
    Cancer Res; 1998 Oct; 58(19):4358-62. PubMed ID: 9766664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-acetylcysteine and sodium 2-mercaptoethane sulfonate as sources of urinary thiol groups in the rat.
    Ormstad K; Ohno Y
    Cancer Res; 1984 Sep; 44(9):3797-800. PubMed ID: 6430554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of urotoxic side effects by regional detoxification with increased selectivity of oxazaphosphorine cytostatics.
    Brock N; Pohl J
    IARC Sci Publ; 1986; (78):269-79. PubMed ID: 3108156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal transport and disposition of Na-2-mercaptoethane sulfonate disulfide (dimesna) in the rat.
    Ormstad K; Uehara N
    FEBS Lett; 1982 Dec; 150(2):354-8. PubMed ID: 6819161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of [14C]-mesna in the rat.
    Shaw IC; Graham MI; Jones MS
    Arzneimittelforschung; 1986 Mar; 36(3):487-9. PubMed ID: 3085684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between mesna and selected transition metals in vitro and in vivo.
    Shaw IC; Weeks MS
    Arzneimittelforschung; 1986 Jun; 36(6):997-1000. PubMed ID: 3091043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of rat hepatic microsomal lipid peroxidation by mesna via glutathione.
    Bast A; Haenen GR; Savenije-Chapel EM
    Arzneimittelforschung; 1987 Sep; 37(9):1043-5. PubMed ID: 3124863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of orally administered mesna.
    Burkert H; Lücker PW; Wetzelsberger N; Breuel HP
    Arzneimittelforschung; 1984; 34(11):1597-600. PubMed ID: 6441581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar bioavailability of single-dose oral and intravenous mesna in the blood and urine of healthy human subjects.
    Goren MP; Houle JM; Bush DA; Li JT; Newman CE; Brade WP
    Clin Cancer Res; 1998 Oct; 4(10):2313-20. PubMed ID: 9796960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of disodium bis-2-mercaptoethanesulphonate (dimesna) in the urine of volunteers after oral dosing.
    Shaw IC; Weeks MS
    Eur J Cancer Clin Oncol; 1987 Jul; 23(7):933-5. PubMed ID: 3117563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interactions of mesna and dimesna with the sulfate exchange in human red blood cells.
    Reuther H; Kohl M; Wildenauer DB
    Arzneimittelforschung; 1986 Apr; 36(4):763-5. PubMed ID: 3087373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic and non-enzymatic mechanisms of dimesna metabolism.
    Cutler MJ; Velenosi TJ; Bodalia A; House AA; Urquhart BL; Freeman DJ
    Amino Acids; 2015 Mar; 47(3):511-23. PubMed ID: 25488427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitro. Its potential use in the treatment of superficial bladder cancer.
    Blomgren H; Hallström M; Hillgren H
    Anticancer Res; 1991; 11(2):773-6. PubMed ID: 1905905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects.
    James CA; Mant TG; Rogers HJ
    Br J Clin Pharmacol; 1987 May; 23(5):561-8. PubMed ID: 3109461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide and mesna.
    Schoenike SE; Dana WJ
    Clin Pharm; 1990 Mar; 9(3):179-91. PubMed ID: 2107997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)].
    Brock N; Stekar J
    Arzneimittelforschung; 1982; 32(5):486-7. PubMed ID: 6809014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of mesna and dimesna after simultaneous intravenous bolus and infusion administration in patients undergoing bone marrow transplantation.
    el-Yazigi A; Ernst P; al-Rawithi S; Legayada E; Raines DA
    J Clin Pharmacol; 1997 Jul; 37(7):618-24. PubMed ID: 9243355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of urinary bladder tumors in cyclophosphamide-treated rats by additional medication with the uroprotectors sodium 2-mercaptoethane sulfonate (mesna) and disodium 2,2'-dithio-bis-ethane sulfonate (dimesna).
    Habs MR; Schmähl D
    Cancer; 1983 Feb; 51(4):606-9. PubMed ID: 6401591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of 2-mercaptoethanesulfonate (mesna) in vitro.
    Blomgren H; Hallström M; Hillgren H
    Methods Find Exp Clin Pharmacol; 1990 Dec; 12(10):691-7. PubMed ID: 2129247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.